Home / Explore Insights / Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury
/ Insights / Explore Insights / Multicenter Validation Of Urinary Cxcl9 As A Risk Stratifying Biomarker For Kidney Transplant Injury
Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury
Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M, Spain K, Ikle, D, Bridges ND, Heeger PS for the CTOT-01 consortium
American Journal of Transplantation. doi: 10.1111/ajt.12426
CTOT
08/21/2013
Publication